Phenergan and Kadian drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phenergan (promethazine hydrochloride) and Kadian (morphine sulfate). Common drug interactions include neuritis among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Phenergan and Kadian. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.

What is Kadian?

Kadian has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 23,045 Kadian users. Check the latest studies of Kadian.



On Jul, 11, 2026

44 people who take Phenergan and Kadian together, and have interactions are studied.

Phenergan and Kadian drug interactions.

What are the common drug interactions of Phenergan and Kadian, by gender? *:

female:

  1. Neuritis (inflammation of nerve)
  2. Panic attack
  3. Patellofemoral pain syndrome (pain in the front of the knee)
  4. Polydipsia (excessive thirst)
  5. Polyuria (production of too much dilute urine)
  6. Psychomotor skills impaired
  7. Temperature intolerance (inability to go in temperature)
  8. Thyroid neoplasm (tumour of thyroid)
  9. Abdominal pain
  10. Cellulitis (infection under the skin)

male:

  1. Pneumonia
  2. Pyrexia (fever)
  3. Back injury
  4. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  5. Dilatation ventricular
  6. Ejection fraction decreased (systolic heart failure)
  7. Frequent bowel movements
  8. Haemoglobin decreased
  9. Muscle oedema (accumulation of free water in muscle)
  10. Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Phenergan and Kadian, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Headache (pain in head)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Balance disorder
  6. Bladder spasm
  7. Breast abscess
  8. Breast cellulitis (spreading, acute inflammation of beast skin)
  9. Breast tenderness
  10. Chest pain

40-49:

  1. Thoracic vertebral fracture
  2. Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
  3. Asthenia (weakness)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Cardiomegaly (increased size of heart than normal)
  7. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  8. Joint effusion (presence of extra fluid in joint covering)
  9. Pleural effusion (water on the lungs)
  10. Pulmonary embolism (blockage of the main artery of the lung)

50-59:

  1. Cellulitis (infection under the skin)
  2. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  3. White blood cell count decreased
  4. Fatigue (feeling of tiredness)
  5. Impaired gastric emptying
  6. Injection site bruising
  7. Myositis (inflammation of the muscles)
  8. Weight increased
  9. Appetite disorder (abnormal eating habits)
  10. Constipation

60+:

  1. Abdominal distension
  2. Abdominal pain
  3. Lack of spontaneous speech
  4. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  5. Muscle spasms (muscle contraction)
  6. Muscle twitching
  7. Pneumonia
  8. Pyrexia (fever)
  9. Renal failure (kidney dysfunction)
  10. Suicidal ideation

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 11 people, 25.00%
  2. Anaemia (lack of blood): 7 people, 15.91%
  3. Multiple Myeloma (cancer of the plasma cells): 5 people, 11.36%
  4. Iron Overload: 5 people, 11.36%
  5. Back Pain: 5 people, 11.36%
  6. Depression: 4 people, 9.09%
  7. Headache (pain in head): 3 people, 6.82%
  8. Growth Hormone Deficiency: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Phenergan and Kadian?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phenergan and Kadian:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phenergan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kadian:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenergan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kadian and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and morphine sulfate (the active ingredients of Phenergan and Kadian, respectively), and Phenergan and Kadian (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: